Overview

Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation

Status:
Unknown status

Trial end date:
2020-12-31

Target enrollment:

Participant gender:

Summary

The study is to evaluate efficacy and safety of low dose of ticagrelor therapy for Chinese unstable angina patients treated with non-urgent coronary stent implantation, to examine whether lower dose ticagrelor (45 mg twice-daily) is not inferior to standard dose (90 mg twice-daily) for the prevention of major adverse cardiovascular and cerebrovascular events, as well as will reduce the incidence of bleeding during long-term treatment.

Phase:

Phase 4

Details

Lead Sponsor:

Xiaofan Wu

Treatments:

Adenosine
Aspirin
Ticagrelor